Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands

Bioorg Med Chem. 2011 Oct 15;19(20):6135-42. doi: 10.1016/j.bmc.2011.08.027. Epub 2011 Aug 24.

Abstract

Newly designed bivalent ligands-opioid agonist/NK1-antagonists have been synthesized. The synthesis of new starting materials-carboxy-derivatives of Fentanyl (1a-1c) was developed. These products have been transformed to 'isoimidium perchlorates' (2a-c). The new isoimidium perchlorates have been successfully implemented in nucleophilic addition reactions, with l-tryptophan 3,5-bis(trifluoromethyl)benzyl ester to give the target compounds-amides (3a-c). Perchlorates (2a-c) successfully undergo reactions with other nucleophiles such as alcohols, amines or hydrazines. The obtained compound 3b exhibited μ-opioid agonist activity and NK1-antagonist activity and may serve as a useful lead compound for the further design of a new series of opioid agonist/NK1-antagonist compounds.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / chemical synthesis*
  • Analgesics, Opioid / chemistry
  • Analgesics, Opioid / pharmacology*
  • Animals
  • Binding Sites
  • Drug Design
  • Guinea Pigs
  • Humans
  • Ligands
  • Male
  • Mice
  • Mice, Inbred ICR
  • Neurokinin-1 Receptor Antagonists*
  • Receptors, Neurokinin-1 / metabolism

Substances

  • Analgesics, Opioid
  • Ligands
  • Neurokinin-1 Receptor Antagonists
  • Receptors, Neurokinin-1